glp-1 and type 1 diabetes Is the Same as Ozempic? Understanding Key Differences Clinical Focus on GLP-1 Agonists
Description
They act as a bridgenot a crutchto sustainable change
In the SURMOUNT 1 trial, tirzepatide at doses of 5 mg, 10 mg and 15 mg were evaluated against placebo, with pooled tirzepatide groups resulting in significant decreases in total cholesterol, LDL-C, VLDL-C, FFA, and triglycerides and an increase in HDL-C at week 72 of follow-up [35]
Compared to placebo, semaglutide increased rates of steatohepatitis resolution without worsening liver fibrosis (63% vs
Mezquita Raya, M
Mechanism of Action
[3] These labs check key markers like blood sugar, cholesterol, liver, kidney, and thyroid function
